# Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects

> **NCT02383888** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 49 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 425809
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02383888
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-11
- **Primary completion:** 2015-08-06
- **Final completion:** 2015-08-06
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02383888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02383888, "Single Rising Dose Trial of BI 425809 for Healthy Japanese and Chinese Male Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02383888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*